NCT04265963: CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1/2 | 45 | RoW | CD123 CAR-T cells | Chongqing Precision Biotech Co., Ltd | Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute | 12/23 | 07/24 | | |
NCT04272125: Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1/2 | 40 | RoW | CD123 CAR-T cells | Chongqing Precision Biotech Co., Ltd | Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute | 12/23 | 07/24 | | |